These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 35962562)

  • 1. Research progress on the relationship between intestinal microecology and intestinal bowel disease.
    Fu Q; Song T; Ma X; Cui J
    Animal Model Exp Med; 2022 Dec; 5(4):297-310. PubMed ID: 35962562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of intestinal microecology in inflammatory bowel disease and colorectal cancer: A review.
    Li H; Wang K; Hao M; Liu Y; Liang X; Yuan D; Ding L
    Medicine (Baltimore); 2023 Dec; 102(51):e36590. PubMed ID: 38134100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases.
    Sun T; Xue M; Yang J; Pei Z; Zhang N; Qin K; Liang H
    J Sci Food Agric; 2021 Aug; 101(11):4456-4463. PubMed ID: 33682122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteolytic activity in inflammatory bowel disease: insight from gut microbiota.
    Hou JJ; Ding L; Yang T; Yang YF; Jin YP; Zhang XP; Ma AH; Qin YH
    Microb Pathog; 2024 Mar; 188():106560. PubMed ID: 38272327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota in inflammatory bowel disease: friend of foe?
    Fava F; Danese S
    World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiota in Inflammatory Bowel Disease.
    Qiu P; Ishimoto T; Fu L; Zhang J; Zhang Z; Liu Y
    Front Cell Infect Microbiol; 2022; 12():733992. PubMed ID: 35273921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial membrane vesicles in inflammatory bowel disease.
    Shen Q; Xu B; Wang C; Xiao Y; Jin Y
    Life Sci; 2022 Oct; 306():120803. PubMed ID: 35850249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on intestinal microecology regulating mechanism and biological activities of polysaccharides].
    Tang T; Chen HG; Zhao C; Gong XJ; Deng QF; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5585-5592. PubMed ID: 34951210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and inflammatory bowel disease.
    Goto Y; Kurashima Y; Kiyono H
    Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity.
    Zeiser R; Warnatz K; Rosshart S; Sagar ; Tanriver Y
    Eur J Immunol; 2022 Sep; 52(9):1406-1418. PubMed ID: 35339113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease.
    Zhou QM; Zheng L
    World J Clin Cases; 2023 Dec; 11(34):8111-8125. PubMed ID: 38130785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity.
    Guo Y; Liu Y; Rui B; Lei Z; Ning X; Liu Y; Li M
    Front Immunol; 2023; 14():1171680. PubMed ID: 37304260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects.
    Yan XX; Wu D
    World J Clin Cases; 2023 Jan; 11(1):47-56. PubMed ID: 36687179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress of Intestinal Microecology in the Pathogenesis of Colorectal Adenoma and Carcinogenesis.
    Zhang Z; Bahaji Azami NL; Liu N; Sun M
    Technol Cancer Res Treat; 2023; 22():15330338221135938. PubMed ID: 36740990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.